Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors by Taylor, P, Fleischmann, R, Takeuchi, T, Pope, J, Genovese, M, Zhu, B, Gaich, C, Zhang, X, Dickson, C, Quebe, A, De Leonardis, F, Cardoso, A, Kouris, I, Durez, P